• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性重型乙型肝炎患者血液中 T 细胞群体和亚群的互补决定区 3 基序的分子特征。

Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B.

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

出版信息

J Transl Med. 2011 Dec 8;9:210. doi: 10.1186/1479-5876-9-210.

DOI:10.1186/1479-5876-9-210
PMID:22152113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3256121/
Abstract

BACKGROUND

T cell receptor (TCR) reflects the status and function of T cells. We previously developed a gene melting spectral pattern (GMSP) assay, which rapidly detects clonal expansion of the T cell receptor β variable gene (TCRBV) in patients with HBV by using quantitative real-time reverse transcription PCR (qRT-PCR) with DNA melting curve analysis. However, the molecular profiles of TCRBV in peripheral blood mononuclear cells (PBMCs) and CD8+, CD8- cell subsets from chronic severe hepatitis B (CSHB) patients have not been well described.

METHODS

Human PBMCs were separated and sorted into CD8+ and CD8- cell subsets using density gradient centrifugation and magnetic activated cell sorting (MACS). The molecular features of the TCRBV CDR3 motif were determined using GMSP analysis; the TCRBV families were cloned and sequenced when the GMSP profile showed a single-peak, indicative of a monoclonal population.

RESULTS

The number of skewed TCRBV in the CD8+ cell subset was significantly higher than that of the CD8- cell subset as assessed by GMSP analysis. The TCRBV11 and BV7 were expressed more frequently than other members of TCRBV family in PBMCs and CD8+, CD8- subsets. Also the relatively conserved amino acid motifs were detected in the TCRBV22, BV18 and BV11 CDR3 in PBMCs among patients with CSHB.

CONCLUSIONS

The molecular features of the TCRBV CDR3 were markedly different among PBMCs and CD8+, CD8- cell subsets derived from CSHB patients. Analysis of the TCRBV expression in the CD8+ subset was more accurate in assessing the status and function of circulating T cells. The expression of TCRBV11, BV7 and the relatively conserved CDR3 amino acid motifs could also help to predict and treat patients with CSHB.

摘要

背景

T 细胞受体(TCR)反映 T 细胞的状态和功能。我们之前开发了一种基因熔解谱图(GMSP)分析方法,该方法通过使用带有 DNA 熔解曲线分析的定量实时逆转录 PCR(qRT-PCR),快速检测乙型肝炎病毒(HBV)患者 T 细胞受体β可变基因(TCRBV)的克隆扩增。然而,慢性重症乙型肝炎(CSHB)患者外周血单个核细胞(PBMC)和 CD8+、CD8-细胞亚群中的 TCRBV 分子谱尚未得到很好的描述。

方法

使用密度梯度离心和磁激活细胞分选(MACS)分离和分选人 PBMC,并分为 CD8+和 CD8-细胞亚群。使用 GMSP 分析确定 TCRBV CDR3 基序的分子特征;当 GMSP 谱显示单峰时,指示单克隆群体,克隆和测序 TCRBV 家族。

结果

通过 GMSP 分析评估,CD8+细胞亚群中的偏倚 TCRBV 数量明显高于 CD8-细胞亚群。TCRBV11 和 BV7 在 PBMC 和 CD8+、CD8-亚群中比 TCRBV 家族的其他成员表达更频繁。在 CSHB 患者的 PBMC 中,TCRBV22、BV18 和 BV11 CDR3 中也检测到相对保守的氨基酸基序。

结论

CSHB 患者的 PBMC 和 CD8+、CD8-细胞亚群中的 TCRBV CDR3 分子特征明显不同。分析 CD8+亚群中 TCRBV 的表达更能准确评估循环 T 细胞的状态和功能。TCRBV11、BV7 和相对保守的 CDR3 氨基酸基序的表达也有助于预测和治疗 CSHB 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e9/3256121/f9e85c524fad/1479-5876-9-210-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e9/3256121/517cafb1bbd9/1479-5876-9-210-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e9/3256121/6867badae4c2/1479-5876-9-210-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e9/3256121/f9e85c524fad/1479-5876-9-210-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e9/3256121/517cafb1bbd9/1479-5876-9-210-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e9/3256121/6867badae4c2/1479-5876-9-210-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e9/3256121/f9e85c524fad/1479-5876-9-210-3.jpg

相似文献

1
Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B.慢性重型乙型肝炎患者血液中 T 细胞群体和亚群的互补决定区 3 基序的分子特征。
J Transl Med. 2011 Dec 8;9:210. doi: 10.1186/1479-5876-9-210.
2
Skewed T-cell receptor beta chain variable gene (TCRBV) usage among different clinical types of patients with chronic HBV infection.慢性乙型肝炎病毒(HBV)感染不同临床类型患者中T细胞受体β链可变基因(TCRBV)使用情况的偏倚
FEMS Immunol Med Microbiol. 2012 Aug;65(3):448-55. doi: 10.1111/j.1574-695X.2012.00969.x. Epub 2012 May 21.
3
Molecular profile of the T cell receptor beta variable in peripheral blood lymphocytes from chronic asymptomatic HBV carriers.慢性无症状乙肝病毒携带者外周血淋巴细胞中T细胞受体β可变区的分子特征
Pathog Dis. 2015 Mar;73(2):1-9. doi: 10.1093/femspd/ftu018. Epub 2014 Dec 4.
4
Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection.活动性肺结核或潜伏性结核感染患者外周血T细胞库中T细胞受体β可变区的分子特征分析。
BMC Infect Dis. 2013 Sep 8;13:423. doi: 10.1186/1471-2334-13-423.
5
The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.外周血CD4(+)CD25(+)调节性T细胞的频率及T细胞受体β链可变区模式的偏态分布与慢性乙型肝炎患者抗病毒治疗期间的乙肝e抗原血清学转换相关。
Cell Mol Immunol. 2016 Sep;13(5):678-87. doi: 10.1038/cmi.2015.100. Epub 2016 Feb 22.
6
Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).在慢性肝衰竭基础上发生的急性肝衰竭患者外周血 CD4(+)CD25(+)调节性 T 细胞(Tregs)表型及临床意义。
J Transl Med. 2012 Sep 15;10:193. doi: 10.1186/1479-5876-10-193.
7
Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection.分析急性乙型肝炎病毒感染康复者外周血淋巴细胞中T细胞受体β链可变基因库。
Cell Mol Immunol. 2014 Jul;11(4):332-42. doi: 10.1038/cmi.2014.22.
8
Analysis of T Cell Receptor Vβ Diversity in Peripheral CD4+ and CD8+ T Lymphocytes Obtained From Patients With Chronic Severe Hepatitis B.慢性重型乙型肝炎患者外周血CD4+和CD8+ T淋巴细胞中T细胞受体Vβ多样性分析
Hepat Mon. 2014 Feb 25;14(2):e15900. doi: 10.5812/hepatmon.15900. eCollection 2014 Feb.
9
Limited T cell receptor beta variable repertoire responses to ESAT-6 and CFP-10 in subjects infected with Mycobacterium tuberculosis.结核分枝杆菌感染者中针对 ESAT-6 和 CFP-10 的 T 细胞受体β可变区反应有限。
Tuberculosis (Edinb). 2013 Sep;93(5):529-37. doi: 10.1016/j.tube.2013.05.007. Epub 2013 Jul 8.
10
Prevalence of an ulcerative colitis-associated CD8+ T cell receptor beta-chain CDR3-region motif and its association with disease activity.溃疡性结肠炎相关的CD8⁺T细胞受体β链互补决定区3(CDR3)区域基序的患病率及其与疾病活动的关联。
J Clin Immunol. 2001 Mar;21(2):126-34. doi: 10.1023/a:1011007922707.

引用本文的文献

1
Human immune repertoire in hepatitis B virus infection.乙型肝炎病毒感染中的人类免疫受体库。
World J Gastroenterol. 2021 Jul 7;27(25):3790-3801. doi: 10.3748/wjg.v27.i25.3790.
2
Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure.乙型肝炎病毒相关慢加急性肝衰竭患者 T 细胞受体库的动态变化。
Hepatol Int. 2020 Jan;14(1):47-56. doi: 10.1007/s12072-019-10008-x. Epub 2019 Dec 23.
3
Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy.

本文引用的文献

1
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.嵌合抗原受体修饰的 T 细胞治疗慢性淋巴细胞白血病。
N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10.
2
Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.替比夫定治疗慢性乙型肝炎对细胞免疫应答的影响。
Antiviral Res. 2011 Jul;91(1):23-31. doi: 10.1016/j.antiviral.2011.04.008. Epub 2011 Apr 23.
3
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.
慢性乙型肝炎患者口服抗病毒治疗后CD4和CD8 T细胞受体库的动态扰动
Front Immunol. 2017 Sep 14;8:1142. doi: 10.3389/fimmu.2017.01142. eCollection 2017.
4
High-Throughput Analysis of the T Cell Receptor Beta Chain Repertoire in PBMCs from Chronic Hepatitis B Patients with HBeAg Seroconversion.HBeAg血清学转换的慢性乙型肝炎患者外周血单个核细胞中T细胞受体β链库的高通量分析
Can J Infect Dis Med Microbiol. 2016;2016:8594107. doi: 10.1155/2016/8594107. Epub 2016 Oct 13.
5
Analysis of T Cell Receptor Vβ Diversity in Peripheral CD4+ and CD8+ T Lymphocytes Obtained From Patients With Chronic Severe Hepatitis B.慢性重型乙型肝炎患者外周血CD4+和CD8+ T淋巴细胞中T细胞受体Vβ多样性分析
Hepat Mon. 2014 Feb 25;14(2):e15900. doi: 10.5812/hepatmon.15900. eCollection 2014 Feb.
6
Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection.活动性肺结核或潜伏性结核感染患者外周血T细胞库中T细胞受体β可变区的分子特征分析。
BMC Infect Dis. 2013 Sep 8;13:423. doi: 10.1186/1471-2334-13-423.
7
Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).在慢性肝衰竭基础上发生的急性肝衰竭患者外周血 CD4(+)CD25(+)调节性 T 细胞(Tregs)表型及临床意义。
J Transl Med. 2012 Sep 15;10:193. doi: 10.1186/1479-5876-10-193.
用于临床前过继免疫治疗研究的小鼠 CD8+和 CD4+ T 细胞的基因工程。
J Immunother. 2011 May;34(4):343-52. doi: 10.1097/CJI.0b013e3182187600.
4
Prospects and limitations of T cell receptor gene therapy.T 细胞受体基因治疗的前景与局限。
Curr Gene Ther. 2011 Aug;11(4):276-87. doi: 10.2174/156652311796150390.
5
Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma.针对肾细胞癌的过继细胞转移的新型基因修饰 T 细胞受体的开发。
J Immunol Methods. 2011 Mar 7;366(1-2):43-51. doi: 10.1016/j.jim.2011.01.002. Epub 2011 Jan 19.
6
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.工程病毒特异性 T 细胞,以靶向 HBV 感染的肝细胞和肝癌细胞系。
J Hepatol. 2011 Jul;55(1):103-10. doi: 10.1016/j.jhep.2010.10.025. Epub 2010 Nov 23.
7
αβ versus γδ fate choice: counting the T-cell lineages at the branch point.αβ 与 γδ 命运选择:在分支点计数 T 细胞谱系。
Immunol Rev. 2010 Nov;238(1):169-81. doi: 10.1111/j.1600-065X.2010.00947.x.
8
Epigenetic control of Tcrb gene rearrangement.Tcrb 基因重排的表观遗传控制。
Semin Immunol. 2010 Dec;22(6):330-6. doi: 10.1016/j.smim.2010.07.002. Epub 2010 Sep 15.
9
Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase.当用靶向酪氨酸酶的高亲和性 TCR 工程改造时,CD4 和 CD8 T 细胞在体内肿瘤治疗中具有同等的有效性。
J Immunol. 2010 Jun 1;184(11):5988-98. doi: 10.4049/jimmunol.1000189. Epub 2010 Apr 28.
10
Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus.儿童乙型肝炎病毒母婴传播免疫预防治疗后的细胞免疫。
BMC Infect Dis. 2010 Apr 28;10:103. doi: 10.1186/1471-2334-10-103.